Appraisal Subcommittee Notice of Meeting, 71550-71551 [2023-22890]

Download as PDF 71550 Federal Register / Vol. 88, No. 199 / Tuesday, October 17, 2023 / Notices lotter on DSK11XQN23PROD with NOTICES1 disk or CD–ROM as CBI and then identify electronically within the disk or CD–ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. 2. Tips for preparing your comments. When preparing and submitting your comments, see the commenting tips at https://www.epa.gov/dockets/ comments.html. II. What action is the Agency taking? EPA requests public comment during the next 30 days on a pesticide petition (available in docket number EPA–HQ– OPP–2023–0323 at https:// www.regulations.gov). The petitioner requests that EPA revoke all remaining tolerances of the pesticide dicofol currently listed under 40 CFR 180.163. The petition is filed pursuant to section 408 of the FFDCA. The petitioner indicates that while he is aware that multiple pesticides are allowed for use on tea, he wishes to ensure that the tea he consumes is free of dicofol residues. The petitioner provides a timeline of the registration and use of dicofol as a pesticide in the United States. The timeline describes an Agency decision on May 9, 2012 (77 FR 27164) in which all dicofol tolerances were revoked except for tolerances on ‘‘tea, dried’ and ‘tea, plucked leaves.’’ The 2012 decision indicated that the Agency would address the tea tolerances and public comments received on them in a future document to be published in the Federal Register. The Tea Association of the U.S.A., Inc. previously provided public comments that dicofol is used in tea production in countries such as India, China, and Argentina, and requested that EPA not revoke the dicofol tolerances on tea but maintain them for importation purposes. The petitioner comments that the Agency did not address the remaining tea tolerances and public comments, as previously indicated in the 2012 decision. Dicofol is an organochlorine miticide that was registered in the United States to control mites on a variety of noncrop areas and on food crops from 1957 to October 31, 2013. All use of dicofol in the United States has been cancelled, and all dicofol tolerances expired on October 31, 2016, except for tolerances on ‘‘tea, dried’ and ‘tea, plucked leaves.’’ VerDate Sep<11>2014 17:02 Oct 16, 2023 Jkt 262001 Background materials related to the Agency’s registration of dicofol and the phase out of its use are available online in public docket EPA–HQ–OPP–2005– 0220 at https://www.regulations.gov. Information related to the Agency’s dicofol tolerance actions are available online in public docket EPA–HQ–OPP– 2012–0171 at https:// www.regulations.gov. Dated: October 11, 2023. Mary Elissa Reaves, Director, Pesticide Re-Evaluation Division, Office of Pesticide Programs. [FR Doc. 2023–22906 Filed 10–16–23; 8:45 am] BILLING CODE 6560–50–P the EPA Administrator issued an order granting in part and denying in part the EIP petition and granting in full the GASP petition. The order itself explains the basis for the EPA’s decision. Sections 307(b) and 505(b)(2) of the CAA provide that a petitioner may request judicial review of those portions of an order that deny issues in a petition. Any petition for review shall be filed in the United States Court of Appeals for the appropriate circuit no later than December 18, 2023. Cristina Ferna´ndez, Director, Air and Radiation Division, Region III. [FR Doc. 2023–22877 Filed 10–16–23; 8:45 am] ENVIRONMENTAL PROTECTION AGENCY BILLING CODE 6560–50–P [FRL–11457–01–R3] FEDERAL ACCOUNTING STANDARDS ADVISORY BOARD Clean Air Act Operating Permit Program; Order on Petitions for Objection to State Operating Permit for United States Steel Corporation, Mon Valley Works Clairton Plant Notice of Issuance of Technical Release 22, Leases Implementation Guidance Updates Environmental Protection Agency (EPA). ACTION: Notice of final order on petition. AGENCY: The Environmental Protection Agency (EPA) Administrator signed an order dated September 18, 2023, on two petitions, each dated March 6, 2023, granting in part and denying in part a petition from the Environmental Integrity Project (EIP), the Clean Air Council (CAC), and Pennsylvania’s Future (PennFuture) (the EIP Petition), and granting in full a separate petition from the Group Against Smog and Pollution (GASP) (the GASP Petition). The petitions requested that the EPA object to a Clean Air Act (CAA) title V operating permit issued by the Allegheny County Health Department (ACHD) to the U.S. Steel Mon Valley Works Clairton Plant (U.S. Steel, Clairton) for its by-products coke plant located in Clairton, Allegheny County, Pennsylvania. FOR FURTHER INFORMATION CONTACT: David Talley, EPA Region III, (215) 814– 2117, talley.david@epa.gov. The final order and petition are available electronically at: www.epa.gov/title-voperating-permits/title-v-petitiondatabase. SUPPLEMENTARY INFORMATION: EPA received the EIP Petition and the GASP Petition, each dated March 6, 2023, requesting that the EPA object to the issuance of operating permit no. 0052– OP22, issued by ACHD to U.S. Steel, Clairton in Allegheny County, Pennsylvania. On September 18, 2023, SUMMARY: PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 Federal Accounting Standards Advisory Board. ACTION: Notice. AGENCY: Notice is hereby given that the Federal Accounting Standards Advisory Board has issued Federal Financial Accounting Technical Release 22 titled ‘‘Leases Implementation Guidance Updates: Amendments to Technical Release 20.’’ ADDRESSES: Technical Release 22 is available on the FASAB website at https://www.fasab.gov/accountingstandards/. Copies can be obtained by contacting FASAB at (202) 512–7350. FOR FURTHER INFORMATION CONTACT: Ms. Monica R. Valentine, Executive Director, 441 G Street NW, Suite 1155, Washington, DC 20548, or call (202) 512–7350. Authority: 31 U.S.C. 3511(d); Federal Advisory Committee Act, 5 U.S.C. 1001–1014. SUMMARY: Dated: October 12, 2023. Monica R. Valentine, Executive Director. [FR Doc. 2023–22860 Filed 10–16–23; 8:45 am] BILLING CODE 1610–02–P FEDERAL FINANCIAL INSTITUTIONS EXAMINATION COUNCIL [Docket No. AS23–16] Appraisal Subcommittee Notice of Meeting Appraisal Subcommittee of the Federal Financial Institutions Examination Council. AGENCY: E:\FR\FM\17OCN1.SGM 17OCN1 Federal Register / Vol. 88, No. 199 / Tuesday, October 17, 2023 / Notices Notice of special closed meeting. ACTION: In accordance with section 1104(b) of title XI of the Financial Institutions Reform, Recovery, and Enforcement Act of 1989, as amended, notice is hereby given that the Appraisal Subcommittee (ASC) met for a Special Closed Meeting on these dates. Location: Virtual meeting via Webex. Date: August 31, 2023 and September 7, 2023. Time: 11:00 a.m. ET. Location: Virtual meeting via Webex. Date: September 22, 2023. Time: 2:01 p.m. ET. SUMMARY: Action and Discussion Item Personnel Matter The ASC convened a Special Closed Meeting to discuss a personnel matter. No action was taken by the ASC. the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than November 16, 2023. A. Federal Reserve Bank of Boston (Prabal Chakrabarti, Senior Vice President) 600 Atlantic Avenue, Boston, Massachusetts 02210–2204. Comments can also be sent electronically to BOS.SRC.Applications.Comments@ bos.frb.org: 1. Eastern Bankshares, Inc., Boston, Massachusetts; to acquire Cambridge Bancorp, and thereby indirectly acquire Cambridge Trust Company, both of Cambridge, Massachusetts. Dated: October 11, 2023. Dharmesh Vashee, General Counsel, Federal Retirement Thrift Investment Board. Board of Governors of the Federal Reserve System. Michele Taylor Fennell, Deputy Associate Secretary of the Board. Medicare Program; CY 2024 Inpatient Hospital Deductible and Hospital and Extended Care Services Coinsurance Amounts [FR Doc. 2023–22889 Filed 10–16–23; 8:45 am] AGENCY: BILLING CODE P James R. Park, Executive Director. Formations of, Acquisitions by, and Mergers of Bank Holding Companies lotter on DSK11XQN23PROD with NOTICES1 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–8083–N] RIN 0938–AV11 Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. October 24, 2023 at 9 a.m. PDT/ 12 p.m. EDT. ADDRESSES: Telephonic. Dial-in (listen only) information: Number: 1–202–599– 1426, Code: 716 481 115#; or via web: https://teams.microsoft.com/l/meetupjoin/19%3ameeting_ M2VhNGNhZjYtODRjYy00NmY 3LWI1NDktY2Q3YjI0YTFkYWE w%40thread.v2/0?context=%7b%22Tid %22%3a%223f6323b7-e3fd-4f35-b43d1a7afae5910d%22%2c%22O id%22%3a%2241d6f4d1-9772-4b51a10d-cf72f842224a%22%7d. FOR FURTHER INFORMATION CONTACT: Kimberly Weaver, Director, Office of External Affairs, (202) 942–1640. SUPPLEMENTARY INFORMATION: Board Meeting Agenda I. Background Open Session Section 1813 of the Social Security Act (the Act) provides for an inpatient hospital deductible to be subtracted from the amount payable by Medicare for inpatient hospital services furnished to a beneficiary. It also provides for certain coinsurance amounts to be subtracted from the amounts payable by Medicare for inpatient hospital and extended care services. Section 1813(b)(2) of the Act requires the Secretary of the Department of Health and Human Services (the Secretary) to determine and publish each year the amount of the inpatient hospital deductible and the hospital and Notice of Board Meeting FEDERAL RESERVE SYSTEM The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The public portions of the applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s Freedom of Information Office at https://www.federalreserve.gov/foia/ request.htm. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of Jkt 262001 BILLING CODE P This notice announces the inpatient hospital deductible and the hospital and extended care services coinsurance amounts for services furnished in calendar year (CY) 2024 under Medicare’s Hospital Insurance (Part A) program. The Medicare statute specifies the formulas used to determine these amounts. For CY 2024, the inpatient hospital deductible will be $1,632. The daily coinsurance amounts for CY 2024 will be as follows: $408 for the 61st through 90th day of hospitalization in a benefit period; $816 for lifetime reserve days; and $204 for the 21st through 100th day of extended care services in a skilled nursing facility in a benefit period. DATES: The deductible and coinsurance amounts announced in this notice are effective on January 1, 2024. FOR FURTHER INFORMATION CONTACT: Suzanne Codespote, (410) 786–7737. SUPPLEMENTARY INFORMATION: FEDERAL RETIREMENT THRIFT INVESTMENT BOARD BILLING CODE 6700–01–P 17:02 Oct 16, 2023 [FR Doc. 2023–22803 Filed 10–16–23; 8:45 am] SUMMARY: [FR Doc. 2023–22890 Filed 10–16–23; 8:45 am] VerDate Sep<11>2014 71551 DATES: 1. Approval of the September 26, 2023, Board Meeting Minutes 2. Monthly Reports (a) Participant Report (b) Legislative Report 3. Quarterly Reports (c) Investment Review (d) Audit Status (e) Budget Review Closed Session 4. Information covered under 5 U.S.C. 552b(c)(6) and (c)(10). Authority: 5 U.S.C. 552b(e)(1). PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 E:\FR\FM\17OCN1.SGM 17OCN1

Agencies

[Federal Register Volume 88, Number 199 (Tuesday, October 17, 2023)]
[Notices]
[Pages 71550-71551]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22890]


=======================================================================
-----------------------------------------------------------------------

FEDERAL FINANCIAL INSTITUTIONS EXAMINATION COUNCIL

[Docket No. AS23-16]


Appraisal Subcommittee Notice of Meeting

AGENCY: Appraisal Subcommittee of the Federal Financial Institutions 
Examination Council.

[[Page 71551]]


ACTION: Notice of special closed meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 1104(b) of title XI of the 
Financial Institutions Reform, Recovery, and Enforcement Act of 1989, 
as amended, notice is hereby given that the Appraisal Subcommittee 
(ASC) met for a Special Closed Meeting on these dates.
    Location: Virtual meeting via Webex.
    Date: August 31, 2023 and September 7, 2023.
    Time: 11:00 a.m. ET.
    Location: Virtual meeting via Webex.
    Date: September 22, 2023.
    Time: 2:01 p.m. ET.

Action and Discussion Item

Personnel Matter

    The ASC convened a Special Closed Meeting to discuss a personnel 
matter. No action was taken by the ASC.

James R. Park,
Executive Director.
[FR Doc. 2023-22890 Filed 10-16-23; 8:45 am]
BILLING CODE 6700-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.